Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 53 out of 100. Biomarkers

Topic: Brain proteins, microglia and lab models

Tau IQ successfully calculated global tau load (Tau L ) in all 791 scans analyzed (range, -3.5% to 185.2%; mean ± SD, 23% ± 20.5%) with a nonzero additional local tau component being required in 31% of all scans (cognitively normal [CN], 22%; mild cognitive impairment [MCI], 35%; dementia, 72%). Tau IQ was compared with the best SUVR approach in the cross-sectional analysis (Tau L increase in effect size: CN- vs. CN+, +45%; CN- vs. MCI+, -5.6%; CN- vs. dementia+, +2.3%) (+/- indicates amyloid-positive or -negative) and correlation with clinical scores (Tau L increase in r 2 : CDR-SB+, 7%; MMSE+, 38%; ADAS-Cog+, 0%). Tau IQ substantially outperformed SUVR approaches in the longitudinal analysis (Tau IQ increase in power: CN+, >3.2-fold; MCI+, >2.2-fold; dementia+, >2.9-fold). Tau L as calculated by Tau IQ provides a superior approach for the quantification of tau PET data. In particular, it provides a substantial improvement in power for longitudinal analyses and the early detection of tau deposition and thus should have significant value for clinical imaging trials in AD that are investigating the attenuation of tau deposition with novel therapies.

Key findings

Why it matters

This paper describes a new image-based method, Tau IQ, for measuring tau load on tau PET scans, which performed better than an existing approach in longitudinal analyses. It is a tool for quantifying scans and is proposed as useful for clinical trials testing treatments that aim to reduce tau deposition.

Study details

How this study scored 53/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 2 of 4; Study design 4 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 3 of 5; Sample size 2 of 4; Effect reported 2 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited 3 of 7; Citations per year 2 of 5; Impact for its field and year 2 of 6; Cited by studies here 2 of 6; Still being cited 1 of 4; Senior author's track record left out, no data; Institution's track record 2 of 3; Multi-centre collaboration 1 of 3; Indexed in PubMed 2 of 2; Free to read 0 of 2. 51 of the 96 points it could be judged on, which is 53 of 100. Total 53 of 100.51 of the 96 points we could judge = 53 of 100

Published in a peer-reviewed journal, and it is a snapshot of people at one point in time. Scored zero for randomised / blinded because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 51 of the 96 points we could judge it on, which is 53 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Journal of nuclear medicine : official publication, Society of Nuclear Medicine)
Journal's citation record 2 / 4 Journal of Nuclear Medicine: journal h-index 230 (OpenAlex, 2026-10-29)
Study design 4 / 12 A snapshot of people at one point in time
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 3 / 5 2021 — within 6 year(s) of the newest study here
Sample size 2 / 4 615 participants
Effect reported 2 / 3 Effect reported as a number, without an interval or test
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 3 / 7 Cited 24 times (OpenAlex, 2026-10-10)
Citations per year 2 / 5 3.4 citations a year over 7 year(s) since 2021
Impact for its field and year 2 / 6 Cited 2.7× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 2 / 6 Cited by 3 other studies in this library
Still being cited 1 / 4 Cited 12 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record — / 4 Senior author's record not available — left out of this score
Institution's track record 2 / 3 Imperial College London: institution h-index 1,744 (OpenAlex)
Multi-centre collaboration 1 / 3 OpenAlex lists 3 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 33517326)
Free to read 0 / 2 Behind a paywall — scores zero
Points 51 / 96 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 51 of the 96 points we could judge it on is 53 out of 100.
Total 53 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — PubMed Central lists this copy as free to read: the link above (checked 10 Oct 2026).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

Whittington, A., Gunn, R. N., & Alzheimer’s Disease Neuroimaging Initiative. (2021). TauIQ: A Canonical Image Based Algorithm to Quantify Tau PET Scans. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. https://doi.org/10.2967/jnumed.120.258962

Vancouver

Whittington A, Gunn RN, Alzheimer’s Disease Neuroimaging Initiative. TauIQ: A Canonical Image Based Algorithm to Quantify Tau PET Scans. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2021. doi:10.2967/jnumed.120.258962. PMID: 33517326.

BibTeX

@article{whittington2021-33517326,
  author  = {Whittington, A. and Gunn, R. N. and {Alzheimer’s Disease Neuroimaging Initiative}},
  title   = {{TauIQ: A Canonical Image Based Algorithm to Quantify Tau PET Scans}},
  journal = {Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
  year    = {2021},
  doi     = {10.2967/jnumed.120.258962},
  pmid    = {33517326},
  url     = {https://doi.org/10.2967/jnumed.120.258962}
}

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 15.

Later studies that cite this one

3 studies in the alzhub library list this one in their references.

Related studies in Biomarkers

Similar studies

More on Biomarkers

See all studies in Biomarkers →